ALADAĞ, E., DEMİROĞLU, H., BÜYÜKAŞIK, Y., TURGUT, M., AKSU, S., SAYINALP, N., . . . GÖKER, H. (2020). CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation. Turk J Med Sci.

ALADAĞ, Elifcan, Haluk DEMİROĞLU, Yahya BÜYÜKAŞIK, Mehmet TURGUT, Salih AKSU, Nilgün SAYINALP, İbrahim Celalettin HAZNEDAROĞLU, Osman İlhami ÖZCEBE, und Hakan GÖKER. "CD34+ Hematopoietic Progenitor Cell Dose As a Predictor of Engraftment and Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation." Turk J Med Sci 2020.

ALADAĞ, Elifcan, et al. "CD34+ Hematopoietic Progenitor Cell Dose As a Predictor of Engraftment and Survival in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation." Turk J Med Sci 2020.